Cargando…
Cancer specific promoter CpG Islands hypermethylation of HOP homeobox (HOPX) gene and its potential tumor suppressive role in pancreatic carcinogenesis
BACKGROUND: We have recently identified HOP hoemobox (HOPX) as a tumor suppressor gene candidate, characterized by tumor-specific promoter DNA hypermethylation in human cancers, and it can remarkably inhibit tumors’ aggressive phenotypes. In this current study, we for the first time examined methyla...
Autores principales: | Waraya, Mina, Yamashita, Keishi, Katoh, Hiroshi, Ooki, Akira, Kawamata, Hiroshi, Nishimiya, Hiroshi, Nakamura, Kazunori, Ema, Akira, Watanabe, Masahiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488580/ https://www.ncbi.nlm.nih.gov/pubmed/22958219 http://dx.doi.org/10.1186/1471-2407-12-397 |
Ejemplares similares
-
The Homeobox Only Protein Homeobox (HOPX) and Colorectal Cancer
por: Yamashita, Keishi, et al.
Publicado: (2013) -
Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer
por: Ooki, Akira, et al.
Publicado: (2011) -
Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer
por: Minatani, Naoko, et al.
Publicado: (2016) -
Identification of EGFR expression status association with metastatic lymph node density (ND) by expression microarray analysis of advanced gastric cancer
por: Ema, Akira, et al.
Publicado: (2015) -
Epigenetic silencing of HOPX is critically involved in aggressive phenotypes and patient prognosis in papillary thyroid cancer
por: Ooizumi, Yosuke, et al.
Publicado: (2019)